Transforming the drugs that transform our world


FAQ 1: What is LaminarPace?
LaminarPace is a patented tool that dries small amounts of chemicals, vaccines, biologics and drug substances—and transforms them from often fragile, difficult-to-transport liquids, into stable, easy-to-transport dry powders. LaminarPace is CE-marked, GLP/GMP ready and has successfully dried over 100 different types of biologics and chemicals. LaminarPace operates at room temperature, so even delicate substances stay active. It is exceptionally low-waste, using just micrograms of test substance (particularly beneficial in early-stage drug testing where test substances can cost tens of thousands of Euros per gram.) And, uniquely, it handles temperature-sensitive materials like proteins and peptides.

Patent reference: US application #12/674,562

FAQ 2: How does LaminarPace work?The process delivers low material losses. Over 100 different types of biologics and chemicals have been dried using the LaminarPace system
FAQ 3: Who is behind LaminarPace?
Per GerdeLaminarPace was invented by world aerosol authority Dr Per Gerde, Associate Professor of Inhalation Toxicology, Institute of Environmental Medicine, Karolinska Institutet. As CSO of Inhalation Sciences AB (ISAB), Dr Gerde originally developed LaminarPace for drying pharmaceutical Candidate Drugs to be used in ISAB’s core technology, PreciseInhale. Realizing that LaminarPace had an extensive number of uses beyond ISAB’s core market, in 2017 LaminarPace was spun-out from ISAB into Ziccum AB—its goal to commercialize the technology towards a wider audience.


Share this: